Entasis Therapeutics Holdings Inc. — Form D

Entasis Therapeutics Holdings Inc. of Waltham, MA, a company, filed a Form D exempt-offering notice with the SEC on 2020-09-10. The offering totals $25.0M, of which $25.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (12)

NameRoleLocation
Heather BehannaDirectorWaltham, MA
David HastingsDirectorWaltham, MA
Howard MayerDirectorWaltham, MA
David MeekDirectorPalm Beach, FL
Manoussos PerrosDirectorWaltham, MA
Heather PrestonDirectorWaltham, MA
David AltaracExecutive OfficerWaltham, MA
Michael GutchExecutive OfficerWaltham, MA
Elizabeth KeileyExecutive OfficerWaltham, MA
John MuellerExecutive OfficerReno, NV
Manoussos PerrosExecutive OfficerWaltham, MA
Ruben TommasiExecutive OfficerWaltham, MA

More